Amer Jaber

Amer Jaber was appointed Executive Vice President Operations Europe in 2019. Amer has extensive international experience in the pharmaceutical industry.

Prior to joining Stallergenes Greer, Amer Jaber was Head of Biotechnology Operations at R-Pharm where he was in charge of developing the long-term strategy and execution of in-house and external technical operations for CMC Development and Manufacturing. He was previously Head of Global Biotech Development and Manufacturing for Technical Operations and Managing Director of UCB Switzerland. Before joining UCB, he held roles of increasing responsibility in product development, quality and manufacturing at Mondobiotech, Serono International and Rivopharm.

He holds a PhD in Medicinal Organic Chemistry from the University of Geneva and has completed various executive leadership programs at Harvard Business School, IMD and Babson College.